CG Oncology names Isabel Kalofonos chief commercial officer
CG Oncology named Isabel Kalofonos as chief commercial officer as it prepares for a potential launch of cretostimogene grenadenorepvec. Kalofonos previously served as chief commercial officer at Crinetics Pharmaceuticals, supporting the launch of PALSONIFY (paltusotine) before its sale to Vertex. She earlier held chief